| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Revenue | $111.7B (+2% YoY) | $112.0B (flat YoY) | Growth stalled completely |
| Adjusted EPS | $7.23 (vs $4.08 prior year) | $6.38 (vs $4.08 prior year) | Sequential decline despite easy comp |
| Medical Care Ratio | 83.9% | 86.7% | +280 bps deterioration Q/Q |
| Operating Earnings | $5.2B | $8.0B (+55% YoY) | Strong recovery but off easy comp |
| Operating Cash Flow | $8.9B (1.4x net income) | $11.0B (1.9x net income) | Quality improvement |
| Days Claims Payable | 44.5 days | 47 days | +2.5 days YoY stretching payables |
| Total Membership | 49.1M domestic | Not disclosed | Stopped reporting total members |
| Medicare Advantage Membership | Expected -1.3M decline | Now expect -1.1M decline | 200k better retention |
| Commercial Medical Trend | ~11% expected | >11% actual | Acceleration when expecting moderation |
| Medicare Medical Trend | ~10% expected | <10% actual | Modest improvement |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.